Collegium Pharmaceutical, Inc.
NASDAQ:COLL
38.78 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 238.947 | 173.688 | 186.426 | 174.116 | 170.019 | 146.633 | 118.697 | 153.225 | 95.697 | 1.634 | 7.551 |
| Short Term Investments
| 71.601 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 310.548 | 173.688 | 186.426 | 174.116 | 170.019 | 146.633 | 118.697 | 153.225 | 95.697 | 1.634 | 7.551 |
| Net Receivables
| 179.525 | 183.119 | 105.844 | 83.32 | 72.953 | 77.946 | 9.969 | 2.129 | 0 | 0 | 0 |
| Inventory
| 32.332 | 46.501 | 17.394 | 15.614 | 9.643 | 7.817 | 1.813 | 1.316 | 0 | 0 | 0 |
| Other Current Assets
| 0.093 | 16.681 | 0.027 | 0.06 | 0.141 | 1.008 | 0.456 | 0.304 | 0.205 | 2.821 | 0.71 |
| Total Current Assets
| 537.6 | 419.989 | 315.543 | 277.888 | 255.72 | 237.512 | 133.484 | 158.575 | 96.883 | 4.496 | 8.261 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 22.012 | 26.382 | 27.135 | 27.379 | 20.901 | 9.274 | 1.826 | 1.038 | 0.738 | 0.514 | 0.693 |
| Goodwill
| 133.857 | 133.695 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 421.708 | 567.468 | 268.723 | 335.904 | 29.503 | 44.255 | 0 | 2.103 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 555.565 | 701.163 | 268.723 | 335.904 | 29.503 | 44.255 | 0 | 2.103 | 0 | 0 | 0 |
| Long Term Investments
| 1.047 | 2.547 | 2.547 | 2.547 | 0 | 0 | 0.097 | 0.097 | 0.097 | 0 | 0 |
| Tax Assets
| 26.259 | 23.95 | 78.042 | -2.547 | 0 | 0 | 0 | -0.097 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.825 | 0.1 | 0.087 | 2.67 | 0.178 | 0.204 | 0.161 | 0.301 | 0 | 0.08 | 0.08 |
| Total Non-Current Assets
| 605.708 | 754.142 | 376.534 | 365.953 | 50.582 | 53.733 | 2.084 | 3.442 | 0.835 | 0.594 | 0.773 |
| Total Assets
| 1,143.308 | 1,174.131 | 692.077 | 643.841 | 306.302 | 291.245 | 135.568 | 162.017 | 97.718 | 5.09 | 9.034 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 8.692 | 39.623 | 33.403 | 34.672 | 39.727 | 42.701 | 5.684 | 17.985 | 5.765 | 2.208 | 1.217 |
| Short Term Debt
| 184.321 | 163.612 | 49.167 | 48.225 | 4.489 | 1.642 | 1.479 | 2.667 | 2.667 | 6.194 | 0.333 |
| Tax Payables
| 7.149 | 4.352 | 3.192 | 1.817 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.944 | -9.548 | 0 | 0 |
| Other Current Liabilities
| 264.902 | 66.879 | 147.829 | 108.329 | 153.06 | 143.141 | 24.325 | -2.667 | 6.881 | 2.015 | 1.068 |
| Total Current Liabilities
| 457.915 | 270.114 | 230.399 | 191.226 | 197.276 | 187.484 | 31.488 | 22.929 | 5.765 | 10.417 | 2.618 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 489.962 | 709.175 | 258.75 | 266.584 | 21.594 | 9.858 | 0 | 1.479 | 4.146 | 6.813 | 0.64 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 2.318 | 7.163 | 2.701 | 2.735 | 0.101 | 0.194 |
| Total Non-Current Liabilities
| 489.962 | 709.175 | 258.75 | 266.584 | 21.594 | 12.176 | 7.163 | 4.18 | 6.881 | 6.914 | 0.834 |
| Total Liabilities
| 947.877 | 979.289 | 489.149 | 457.81 | 218.87 | 199.66 | 31.488 | 27.109 | 12.646 | 17.331 | 3.452 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97.718 | 77.107 | 73.807 |
| Common Stock
| 0.038 | 0.037 | 0.036 | 0.035 | 0.034 | 0.033 | 0.033 | 0.029 | 0.021 | 0.008 | 0.001 |
| Retained Earnings
| -233.189 | -281.344 | -256.342 | -333.147 | -359.899 | -337.177 | -298.049 | -223.184 | -129.008 | -101.753 | -80.536 |
| Accumulated Other Comprehensive Income/Loss
| 0.014 | 0 | -0 | -0 | 0 | 0 | -1.668 | -1.332 | -1.074 | -0.903 | -0.716 |
| Other Total Stockholders Equity
| 428.568 | 476.149 | 459.234 | 519.143 | 447.297 | 428.729 | 403.764 | 359.395 | 117.415 | 13.3 | 13.026 |
| Total Shareholders Equity
| 195.431 | 194.842 | 202.928 | 186.031 | 87.432 | 91.585 | 104.08 | 134.908 | 85.072 | -12.241 | 5.582 |
| Total Equity
| 195.431 | 194.842 | 202.928 | 186.031 | 87.432 | 91.585 | 104.08 | 134.908 | 85.072 | -12.241 | 5.582 |
| Total Liabilities & Shareholders Equity
| 1,143.308 | 1,174.131 | 692.077 | 643.841 | 306.302 | 291.245 | 135.568 | 162.017 | 97.718 | 5.09 | 9.034 |